Literature DB >> 4324836

Chlorpropamide and tolbutamide inhibition of adenosine 3'5' cyclic monophosphate phosphodiesterase.

G Brooker, M Fichman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4324836     DOI: 10.1016/0006-291x(71)90504-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  Non-hormonal drugs for the treatment of diabetes insipidus.

Authors:  T Nawar; J Genest
Journal:  Can Med Assoc J       Date:  1972-12-23       Impact factor: 8.262

2.  Role of calcium and cyclic adenosine 3',5'-monophosphate in the antilipolytic effect of tolbutamide and glibenclamide.

Authors:  R Ebert; O Hillebrandt; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.

Authors:  K C Lasseter; G S Levey; R F Palmer; J S McCarthy
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

4.  Direct effect of glibenclamide on guanylate cyclase activity in the rat in vitro.

Authors:  D L Vesely
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

5.  The clinical physiology of water metabolism. Part II: Renal mechanisms for urinary concentration; diabetes insipidus.

Authors:  R E Weitzman; C R Kleeman
Journal:  West J Med       Date:  1979-12

6.  Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus.

Authors:  E Kusano; J L Braun-Werness; D J Vick; M J Keller; T P Dousa
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

Review 7.  Cyclic AMP dynamics in the pancreatic β-cell.

Authors:  Anders Tengholm
Journal:  Ups J Med Sci       Date:  2012-09-13       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.